NRXP icon

NRX Pharmaceuticals

20 hedge funds and large institutions have $44.1M invested in NRX Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Holders
20
Holders Change
+1
Holders Change %
+5.26%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
HIM
1
HGC Investment Management
Ontario, Canada
$4.82M 481,257 +5,000 +1%
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$4.69M 468,300
OAM
3
Oxford Asset Management
United Kingdom
$4.47M 447,635 +35,000 +8%
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$3.53M 352,385
BFM
5
Boothbay Fund Management
New York
$3.01M 300,000
BI
6
Bulldog Investors
New Jersey
$2.85M 285,226 +39,559 +16%
PC
7
Periscope Capital
Ontario, Canada
$2.53M 252,000
KIM
8
Karpus Investment Management
New York
$2.51M 251,017 -1,900 -0.8%
WCMNY
9
Westchester Capital Management (New York)
New York
$2.45M 244,758
RCM
10
Rivernorth Capital Management
Florida
$2.4M 239,998 +59,916 +33%
WRBC
11
W.R. Berkley Corp
Connecticut
$2.03M 202,748
AA
12
AQR Arbitrage
Connecticut
$2M 200,000
GCL
13
Glazer Capital LLC
New York
$1.72M 172,013 -20,200 -11%
YCM
14
Yakira Capital Management
Connecticut
$1.65M 165,000
KPF
15
K2 Principal Fund
Ontario, Canada
$1.34M 134,191 -12,200 -8%
LIM
16
Longfellow Investment Management
Massachusetts
$972K 97,067 +97,067 New
BCM
17
Basso Capital Management
Connecticut
$537K 53,600
HCMT
18
Highland Capital Management (Texas)
Texas
$516K 51,500 +24,133 +88%
BCM
19
Bluefin Capital Management
New York
$32K 101,600
Walleye Trading
20
Walleye Trading
New York
$3K 300 +300 New
UBS Group
21
UBS Group
Switzerland
-1,300 Closed
CFGS
22
Concourse Financial Group Securities
Alabama